医学--唑来膦酸的抗肿瘤特性.ppt

  1. 1、本文档共45页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
医学--唑来膦酸的抗肿瘤特性

* * * * * * * * AZURE研究根绝月经状态分层分析 低雌激素水平患者使用ZOL带来DFS获益 Typical Odds Ratio 月经状态分层分析 绝经前、绝经 5年 及月经状态不明 绝经5 年 ?21 (heterogeneity) = 5.34; P = .02 Odds Reduction (± SD) 1.2 1.4 1.6 1.8 2.0 0.2 0.4 0.6 0.8 N = 1,041 247 events N = 2,318 505 events 高雌激素水平 低雌激素水平 HR = 0.76 (95% CI = 0.60, 0.98) HR = 1.13 (95% CI = 0.95, 1.35) CI = confidence interval; DFS = disease-free survival; HR = hazard ratio; SD = standard deviation. *Adjusted for imbalances in estrogen receptor status, lymph node status, and T stage. Coleman RE, et al. SABCS 2010. Abstract S4-5. Figures reprinted courtesy of Prof. RE Coleman. ZOM130717136 AZURE 绝经前亚组分析: ZOL vs No ZOL 无DFS及OS差异 CI = confidence interval; CTL = control; DFS = disease-free survival; HR = hazard ratio; OS = overall survival; ZOL = zoledronic acid. Left image reprinted from Coleman RE, et al. NEJM. 2011 Sept 25 Epub; right image adapted from Coleman RE, et al. SABCS 2010, abstract S4-5. DFS事件 DFS Events, n 228 (20.2%) 261 (23.1%) Total events n = 1,127 n = 1,131 Adjusted HR = 0.97 (95% CI = 0.78, 1.21) P = .81 161 vs 165 events 绝经前、围绝经期、及月经状态不明 1.0 Proportion Surviving 0.8 0.6 0.4 0.2 0.0 No. at Risk ZO L 0 Time Since Randomization, months 6 12 18 24 30 36 42 48 54 60 66 72 78 84 1 ,162 1 ,131 1,078 1,020 955 466 71 0 Control 1 ,156 1 ,123 1,076 1,032 963 446 60 0 Control ZOL ZOM130717136 0 Overall Survival ? 26% AZURE 绝经后亚组分析: ZOL有效改善OS及减少DFS事件 1 2 3 4 5 6 7 20 40 60 80 Time, years Zoledronic acid (n= 519) Control (n = 522) Adjusted HR = 0.74 P = .04 0 100 Patients Surviving, % n = 551 n = 550 DFS Events* DFS Events, n *This analysis included women 60 y old with unknown menopausal status in the postmenopausal 5 y group. DFS = disease-free survival; OS = overall survival; ZOL = zoledronic acid. Left image reprinted from Coleman RE, et al. NEJM. 2011 Sept 25 Epub; right image adapted from Coleman RE, et al. SABCS 2010, abstract S4-5. ZOM130717136 AZURE 结论 辅助 ZOL并不能为所有

文档评论(0)

gz2018gz + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档